How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

Last updated: October 9, 2024
Sponsor: University of Pennsylvania
Overall Status: Active - Recruiting

Phase

N/A

Condition

Obsessive-compulsive Disorder

Treatment

Exposure & Response Prevention (EX/RP)

Clinical Study ID

NCT05359562
1R01MH121608-01A1
1R01MH121597-01A1
  • Ages 18-45
  • All Genders

Study Summary

Studies show that hormones affect the brain's fear extinction network, which is relevant for therapy involving exposure and response prevention (EX/RP), a first-line treatment for obsessive compulsive disorder (OCD). This study will examine the effect of delivering EX/RP to women during different phases in their menstrual cycle to determine the effects of hormones on the fear extinction network and on their OCD symptoms.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Diagnosis of OCD;

  2. Male and female subjects aged between 18- 45;

  3. Women must be menstruating and regularly cycling

  4. Ability to tolerate a treatment-free period;

  5. No psychotropic medication in the past 12 weeks

  6. At entry, at least moderate severity OCD

  7. Willingness and ability to give written informed consent after full explanation ofstudy procedures.

Exclusion

Exclusion Criteria:

  1. Use of birth control (oral contraception or IUD) that affects the menstrual cycle,or menopause.

  2. Pregnancy. Women of childbearing potential will be required to sign a statementindicating their intention to avoid pregnancy during the study.

  3. Neurologic or medical condition that would prevent safe participation in the fullstudy protocol.

  4. Any contradiction to magnetic resonance imaging (e.g., metallic implants ordevices).

  5. Comorbid psychiatric conditions that significantly elevate the risks associated withstudy participation or confound results.

  6. Patients with prominent suicidal ideation or with a recent suicide attempt.

  7. Current psychotherapy

Study Design

Total Participants: 120
Treatment Group(s): 1
Primary Treatment: Exposure & Response Prevention (EX/RP)
Phase:
Study Start date:
June 15, 2022
Estimated Completion Date:
June 30, 2026

Study Description

This study involves neuroimaging and a brief EX/RP protocol. The investigators will recruit both male and female participants. All participants will complete neuroimaging, hormonal assays and symptom ratings before and after a brief course of EX/RP. Female participants will be randomized to complete brief EX/RP during distinct phases of their menstrual cycles. This design will allow the investigators to study the effects of hormonal variation during the menstrual cycle and sex on the fear extinction network and on EX/RP outcome. The long-term goal is to optimize EX/RP for individuals suffering from OCD. Men will also be recruited for this study to further explore biological sex differences. The results will elucidate treatment mechanisms and could lead to personalized treatment recommendations for women with OCD.

Connect with a study center

  • New York State Psychiatric Institute

    New York, New York 10032
    United States

    Suspended

  • University of Pennsylvania

    Philadelphia, Pennsylvania 19104
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.